Miromatrix – Medical Alley Association

Miromatrix

In the Know: Healthcare News from Medical Alley for December 9, 2019

John Halamka named president of Mayo Clinic Platform NeuroOne Medical Technologies Corporation Receives FDA 510(k) Clearance for Evo(TM) Cortical Electrode Abilitech Medical raises $7.4 million Dr. Craig Samitt Headlines Medical Alley Representation on TCB 100 List Boston Scientific sells Zytiga royalties for $256m Case report: Stem cells a step toward improving motor, sensory function after […]

Miromatrix Awarded $1.9 Million NIH Grant to Advance the Development of a Bioengineered Liver

Miromatrix Inc., a Minnesota-based biotechnology company, was awarded a $1,970,000 Direct to Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to advance the development of a bioengineered transplantable liver to address the chronic shortage of transplantable […]

In the Know: Healthcare News for Oct. 21, 2019

These are some of the best companies we saw at TCSW How Medtronic could help change healthcare for the better Nothing Basic About Abbott’s Diabetes Deal with Tandem What executives at UHG and Mayo want you to know before you pitch NIH-funded research consortium to target frontotemporal lobar degeneration Medtronic to Buy Israeli Catheter Developer […]

Reprise Biomedical Raises $12.5 Million and Completes Spin-Off From Miromatrix Medical

New Minnesota-based medical device company focuses on biological medical devices manufactured using perfusion decellularization technology. Minneapolis, Minn. (July 1, 2019) – Reprise Biomedical, Inc., a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology, has successfully completed a $12.5 million private placement and commenced operations as a spin-off from […]

In the Know: Healthcare News for June 17, 2019

‘What if we become the change we want to see’? We got a look at the slide deck of Bind, a startup that’s raised $70 million to upend the way we pay for healthcare Abbott touts real-world CGM data at diabetes conference AED Leader Cardiac Science Agrees to Be Acquired by ZOLL Upsher-Smith Laboratories Enters […]

For the Record with Dr. Jeff Ross, CEO, Miromatrix

Dr. Ross brings more than 20 years of biomedical research, management and regulatory experience in regenerative medicine, biologics, and medical devices to Miromatrix including concept development, preclinical, clinical, manufacturing, and commercialization.  He has held various technical and management positions at Guidant, Athersys and SurModics.  Since coming to Miromatrix in 2010 he has been pivotal in […]

In the Know: Healthcare News for May 20, 2019

Abbott Partners With NIH On BRAIN Initiative to Advance Research for Neurological Disorders Generic drugmaker Upsher-Smith plans Maple Grove expansion CVRx data show its device can benefit heart-failure patients 76% of Patients Positively Impacted Within 12 weeks in new MIRODERM Clinical Study Bright Health to expand into 5 new states next year VentureMed Group Grows […]

In The Know — Healthcare News for May 3, 2019

3M buying Acelity in deal worth $6.7B Medtronic wins FDA approval for CareLink SmartSync CRM device manager Biotech firm Miromatrix Receives KidneyX Redesign Dialysis Phase I award NIH taps StemoniX’s organ-on-a-chip for opioid, addiction research Report: Takeda adopts value-based pricing for Crohn’s stem cell therapy in Europe Med-tech firm NeoChord adds $7M to earlier $25M […]

In the Know — Healthcare News From Medical Alley, April 29, 2019

NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Million Boston Scientific wins FDA approval for Lotus Edge TAVR Bright Health CEO Bob Sheehy on how the business has grown since record $200 million funding deal Matt Miller, head of UnitedHealthcare accelerator, says applications are flooding in […]

New Study Utilizing Miromesh® Biologic Matrix Reports Excellent Patient Outcomes with No Reinterventions

New Study Reports Excellent Patient Outcomes with No Reinterventions at Two Years in Patients Who Underwent Laparoscopic Paraesophageal Hernia Repair Utilizing MIROMESH® Biologic Matrix A new study published in The American Journal of Surgery demonstrates improved long-term patient outcomes, with no reinterventions, and a 10% two-year radiographic recurrent rate when MIROMESH® Biologic Matrix was utilized […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER